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Abstract
Background: New National Institutes of Health policies call for expansion of practice-based research to improve
the clinical research enterprise and facilitate dissemination of evidence-based medicine.
Objective: This paper describes organizational strategies that influence clinicians’ decisions to participate in clinical
research.
Design: We reviewed the literature and interviewed over 200 clinicians and stakeholders.
Results: The most common barriers to community clinician participation in clinical research relate to beliefs that
clinical research is too burdensome and has little benefit for the participating clinician or patient. We identified a
number of approaches healthcare organizations can use to encourage clinicians to participate in research,
including an outreach campaign to promote the benefits of clinical research; selection of study topics of interest to
clinicians; establishment and enforcement of a set of research principles valuing the clinician and patient;
development of a transparent schedule of reimbursement for research tasks; provision of technological and
technical assistance to practices as needed; and promotion of a sense of community among clinicians involved in
practice-based research.
Conclusions: Many types of existing healthcare organizations could provide the technical and intellectual
assistance community clinicians need to participate in clinical research. Multiple approaches are possible.
Background
The National Institutes of Health (NIH) and other pol-
icymakers have identified broader recruitment of com-
munity-based physicians and their patients into large-
scale clinical studies as a priority for the national health
research agenda [1-3]. Meeting this goal will require
recruiting many clinicians who would not typically parti-
cipate in clinical research [2-4]. The NIH [5] has called
for practitioners to commit to stable, long-term partici-
pation. Thus, recruitment and training need to be tai-
lored to meet this expectation. We and others have
identified many barriers to long-term participation in
clinical research by community physicians and other
clinicians, including time constraints, insufficient staff
and training, concern about negative impact on doctor-
patient relationships, clinician discomfort with the
informed consent process, and overly rigid eligibility
requirements [6-11]. Interestingly, many of the factors
practitioners identify as barriers to participation in clini-
cal research also contribute to inefficiencies in clinical
care (for example, rising costs, slow results, and frag-
mented infrastructure) [12]. Thus, identifying support
services that improve the efficiency of medical practice
as well as research and lead to reduced costs should
also make it easier to recruit community practitioners
for long-term research participation.
Methods
We conducted a literature review and interviews with
over 200 clinicians and stakeholders to identify factors
that limit or enhance community clinician involvement
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any medium, provided the original work is properly cited.in clinical research, and to examine the role that health-
care organizations might play in removing the barriers
to involvement. Interviewees were identified through
‘snowball sampling,’ with efforts made to ensure a
diverse sample with respect to demographics as well as
knowledge and experience base. Snowball sampling is a
technique for developing a research sample where exist-
ing study subjects recruit future subjects from among
their acquaintances. Between September 2004 and Sep-
tember 2005, a total of 243 participants were inter-
viewed, including 112 clinicians whose reports of
barriers to participation in research informed this analy-
sis (see Kahn et al., for more detailed description of the
research methods [6]). The remaining participants with
expertise in the conduct of clinical research in commu-
nity settings contributed to our development of strate-
gies for addressing clinicians’ concerns.
After each interview, the interviewer(s) identified key
themes and issues that arose during the interview and
presented these at a weekly investigator debriefing meet-
ing. This approach served to facilitate rapid sharing of
new information and themes identified and to identify
issues that should be further developed in upcoming
interviews. Additionally, two or more investigators
reviewed all transcripts within two weeks of the inter-
view to identify key themes. This attention to detail
resulted in a key issues content change between the
early and the late interviews.
Kahn et al. described the barriers we identified for
clinician participation in research within the context of
their own community practices and proposed a num-
ber of innovations to remove them [6]. In the Results
section of this article, we document concerns reported
by clinicians that influence their decisions about
whether or not to incorporate clinical research into
the context of their community practices. We also pre-
sent respondent reports of suggested strategies to over-
come concerns. We organized this text around a
model of clinical research participation decision-mak-
ing selected and adapted by the research team based
on our study results [13].
Recognizing the importance of partnerships and infra-
structure in supporting complex activities, such as sus-
tained research activities within the context of ongoing
clinical practice, we then present strategies that health-
care organizations can use to address clinician concerns.
These strategies should increase the likelihood that clin-
icians will choose – in a sustained way – to incorporate
into their practices research that could inform clinical
questions, methods, analyses, and clinical recommenda-
tions built upon their own patients. These strategies are
d e r i v e df r o mt h er e s e a r c ht e a m ’s synthesis of clinician
self-reports, literature review, and internal discussions.
We probed informants and searched the literature to
identify potential strategies. We then conducted further
interviews of community clinicians and other key stake-
holders for their assessments of these strategies and the
roles that healthcare organizations might play. Where
relevant, we applied potential strategies to specific bar-
riers or issues identified through clinician self-report
interviews.
The RAND institutional review board (IRB) reviewed
these materials and procedures prior to the start of the
interviews.
Results
The results of our initial interviews and literature review
suggested that the decision-making processes of clini-
cians contemplating participation in clinical research are
similar to the decision-making processes of people con-
templating changes in health behaviors (Figure 1) [13].
We next organized the potential strategies for overcom-
ing clinician concerns according to the stage of the
research participation model most directly addressed by
each strategy (see Table 1).
Pre-awareness
With their main responsibility being the clinical care of
patients, many clinicians said that they were unaware of
opportunities to engage in clinical research. Conse-
quently, some clinicians said that they would consider
participating in a clinical research study, but they did
not know where to learn about such opportunities.
Awareness
Simply knowing about clinical research opportunities is
insufficient. When we asked community clinicians what
factors shape their attitudes toward clinical research, we
learned that even if they were informed of research
opportunities, they would need to value clinical research
and believe that it is potentially beneficial to their
patients and practices to be willing to invest the time
and energy necessary to evaluate whether a particular
research project would make sense for them. Some clin-
icians mentioned the benefits of intellectual stimulation
and personal satisfaction derived from being a part of
clinical trials. As one clinician observed, ‘being able to
participate can sometimes be exciting because you hear
about cutting-edge things. And that can be rewarding.’
Other clinicians emphasized that they would partici-
pate only if the study topic was pertinent to their inter-
ests or practices or if they were familiar with the
treatment being considered. Some community clinicians
stated that many research questions were irrelevant to
their practices or that most studies have overly rigid
eligibility requirements that would disqualify many of
their patients [11,14,15]. Clinicians also reported they
would be more likely to commit to clinical research if
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their participation. For example, one informant noted
that clinicians might participate if ‘their participation is
seen as valuable’ by patients, other clinicians, and the
clinical research staff. Some clinicians expressed distrust
or the belief that their patients distrust clinical research
[16,17]. Community clinicians often expressed the con-
cern that they or their patients might be exploited for
research purposes, and that interest in their participa-
tion in research might not be based upon their potential
intellectual and professional contributions.
Information-gathering
If clinicians were aware of and interested in clinical
research, they still need to evaluate its financial, liability,
and resource implications carefully. Clinicians stressed
that preservation of a viable clinical practice is of para-
mount concern. As an informant from a clinical
research organization noted:
’People don’t do this for the greater good. They don’t
have time, and they can’t afford to do it. They do it
because it’s a reasonable business proposition that also
blends with their medical interest. You really have to
think about this as, am I going to be able to, at the end
of the day, pay my staff, pay my rent, and bring home
enough money to make this worth doing? This is an
additional possible activity to get involved in, and it’s
got to make some economic sense.’
Deciding if and how incorporating clinical research
might jeopardize or benefit the practice requires more
time and expertise than reported as available for most
clinicians who have not participated in a research study.
Despite time constraints, prior to initiating research par-
ticipation, clinicians said it is critical to make time to
accurately estimate how clinical research is likely to
affect patient load, patient flow, and other essential
practice characteristics. Specifically, clinicians reported
that they could benefit from help thinking through the
‘business implications of participating in protocols, staff-
ing needs associated with research activities, strategies
for adjusting an office practice so that clinical research
does not adversely affect patient flow, and identifying
ways to assure high quality data’. Clinicians said they
need detailed information about what types of research
tasks they will be asked to conduct. Clinicians also
reported they want to be fairly reimbursed for their
Information-gathering 
Community physicians carefully evaluate the implications of 
research involvement for their practices before committing 
to research participation. 
Maintenance 
Community physicians conduct their second and subsequent research 
studies successfully and realize professional or personal benefits. 
First protocol 
Community physicians select and successfully complete a first 
research study without adverse consequences to their practice or 
patients. 
Awareness 
Community physicians form intentions to participate 
in clinical research they believe to be beneficial, 
without major barriers, and valued by those whose 
opinions matter to them. 
Pre-awareness 
Community physicians become aware of 
potential research opportunities that they may 
be eligible for. 
Figure 1 A Decision model to participate in clinical research studies [33].
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told us that reimbursement levels for pharmaceutical
studies are break-even, and that those for NIH-spon-
sored research fall short of cost. Such observations have
led to calls for greater equity in reimbursement across
types of studies [18].
Participating in a research study
If a clinician decides that a clinical research study makes
sense for the practice, he or she may decide to partici-
pate. Community clinicians who were experienced
researchers overwhelmingly emphasized several pro-
blems they encountered in their initial research
Table 1 Overcoming barriers to community clinician-participation in clinical research through organizational support
Model
phase
Barriers to participation Organizational solutions
Pre-
Awareness
1. Community clinicians do not know about clinical research
studies they may be eligible to participate in.
1. Conduct a multi-media outreach campaign to educate
Clinicians about possible research opportunities. Identify and
reach all potentially eligible Clinicians.
Awareness 1. Clinicians do not appreciate potential personal or professional
benefits to clinical research. They feel research questions are not
pertinent to their patients.
1. As part of an outreach campaign, craft messages that highlight
benefits to Clinicians and patients, as well as the value of clinical
research to the organization. When possible, provide relevant
research studies with topics of interest to clinicians, with
minimum exclusion criteria, or solicit clinician input on these areas
and channel results to study sponsors.
2. Clinicians believe that research tasks are too difficult to
successfully implement in community practice.
2. As part of an outreach campaign, identify and address barriers
to research participation that are especially problematic within
clinicians’ systems, and effectively communicate to clinicians how
these barriers will be addressed.
3. Clinicians do not believe that clinical research is valued by
colleagues or patients.
3. Develop and articulate clinical research principles that value
clinicians and patients and with a clear set of standards that
clinicians and other research participants must adhere to.
Information-
Gathering
1. Clinicians have insufficient information or ability to carefully
evaluate the business, clinical, and resource implications of
participating in research.
1. Provide informational and instrumental assistance pertinent to
the business implications of participation. Explain how
reimbursement is set for clinical research. Explain study protocol
and training requirements. Review checklist for costs. Evaluate and
check appropriateness of liability insurance.
2. Clinicians face considerable uncertainty about levels of
reimbursement they can expect and about future additional
research opportunities they can expect.
2. Develop a reimbursement schedule for research tasks clinicians
can peruse to assess impact of clinical research on practice
revenue. Post planned future studies on a Web-based registry to
enable planning for future research engagement.
First
Protocol
1. Clinicians have insufficient time or resources to register and
train for a first protocol. For example, they do not know how to
confirm with insurer that liability covers research-related tasks,
interact with IRB, etc.
1. Provide informational and instrumental assistance from
selection of the first protocol through to its successful completion.
Review management and fiscal aspects of all procedures/tasks
with clinicians. Explain the study reimbursement schedule
including reimbursements and insurance coverage. Clarify areas of
uncertainty. Provide administrative and technical support as
needed. Work with clinicians to complete IRB requirements–
identify and guide interactions with IRBs. Ensure that all
administrative requirements are met.
2. Clinicians do not know which protocol will provide the best ‘fit’
with the practice and maximize likelihood of meeting recruitment
goals, collecting quality data, and not disrupting patient care and
administrative tasks.
2. Provide consultation on protocol selection, setting enrollment
goals and study timelines, and on QA procedures.
3. Clinicians and their staff are uncertain about how to most
effectively adjust workflow to accommodate research tasks.
3. Provide technology and technical support, such as a personal
computer, fax machine with encryption software, and telephone
computer support to help practices that do not have the
technology or expertise.
Maintenance 1. Clinicians suffer repeated financial losses from research
involvement.
1. Set or advocate for transparent study reimbursement schedules
that fairly compensate clinicians for their time and effort. Provide
consultation and audits to clinicians throughout each study as
needed.
2. Clinicians fear loss of patients to specialists because of
research-related referrals.
2. Establish ethical principles of research that emphasize that
poaching will not be tolerated, and closely monitor all principles.
3. Clinicians do not feel that they are valued for their intellectual
and clinical contributions–that they are being used for their
patients.
3. Encourage a sense of research community. Recognize clinicians
for their contribution and expertise. Provide a confidential venue
such as a website portal to register queries/complaints/concerns
about current and future protocols, continue to solicit clinician
opinion about future research topics.
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ciated with IRB applications, report generation, and
communication with the principal investigator, data-
coordinating center, and regulatory agencies regarding
protocol design, protocol changes, IRB changes, and
data quality. Both individual providers and leaders of
large provider or research organizations emphasized that
the Health Insurance Portability and Accountability Act
(HIPAA), in particular, fundamentally changed the way
data were gathered and disclosed, mystified many provi-
d e r s ,a n dw a se n o u g ht ok e e pt h e mf r o mp a r t i c i p a t i n g
in clinical trials. Several informants said that access to
shared and experienced study coordinators or nurses
can help new researchers avoid or minimize these kinds
of problems, enhancing the probability that initial
research experiences are successful. One research net-
work representative noted that ‘a lot of the work we
can’t necessarily turn over entirely to the practices and
t h ep r a c t i t i o n e r sb e c a u s et h e yj u s td o n ’th a v et h em a n -
power.’ By using a study coordinator, ‘one investigator
can do a lot of research because they’re typically only
involved in actually seeing the patient at the first and
last visit. The study coordinator sees all the patients in
between.’
Clinicians without prior research experience also cited
the need for technological or technical support. Clini-
cians observed that some practices might need a fax
machine with encryption software, a DSL line, or an
extra computer.
Maintenance
If a clinician’s first research experience is successful – e.
g., the research protocol is well integrated into practice
workflow and the practice loses no (or minimal) revenue
– the clinician is likely to participate in subsequent stu-
dies. An unsuccessful research experience may discou-
rage a clinician, particularly one who is inexperienced at
practice-based research, from participating in a subse-
quent study. As one informant observed, ‘The challenge
is 90% of the 46,000 [providers who filled out a state-
ment of Investigator (Form FDA 1572)] will never do
the third trial. But they get into it thinking they were
going to start a research business. They walk in and
anoint their office nurse study coordinator for the day.
They do two trials and they look at each other and say,
boy this is a whole lot harder than we ever thought.
We’re not going to do this any more.’ More experienced
clinicians indicated they require less administrative and
technical support. However, they said they could still
benefit from assistance in setting and meeting enroll-
ment goals so that recruitment efforts and research
activities do not swamp their clinical responsibilities.
They may also need some assistance with quality assur-
ance checks and audits.
Discussion
We identified a series of concerns voiced by clinicians
about barriers to clinician participation in clinical
research. Building upon the model described above to
account for decision making about participation in clini-
cal research and the research team’s synthesis of clini-
cian self-reports, literature review, and internal
discussions, the research team developed specific strate-
gies that healthcare organizations could use to address
clinician concerns.
Strategies for overcoming barriers to clinical
engagement, by decision-making stage
The research team identified themes, drew from the lit-
erature, and probed with subsequent informants about
potential strategies for overcoming barriers to clinical
research in an iterative process. Below, we describe the
resulting strategies, organized by stage of our conceptual
decision-making model.
Pre-awareness
Organizations can address a lack of awareness of
research opportunities by carefully designing outreach
campaigns [12,16,18,19] for community clinicians. Care
should be taken to ensure that all potentially eligible
clinicians are identified and reached through multiple
venues, including professional journals and meetings,
websites for professional practice organization, newslet-
ters, emails, mailings, and word-of-mouth.
Practice-based research networks (PBRNs) have suc-
cessfully raised awareness of community clinicians
regarding participation in research studies by encoura-
ging them to preferentially participate in studies consis-
tent with their personal and professional areas of
interest [19]. Furthermore, PBRNs preferentially recom-
mend community practitioners’ participation in studies
with designs that demonstrate the feasibility of conduct-
ing research in community-based clinical practice.
Awareness
Clinicians reported that they are more likely to commit
to clinical research if their patients, colleagues, and
healthcare organizations value their efforts. An outreach
campaign could be crafted to emphasize the multiple
ways that clinical research can benefit clinicians and their
patients. It might emphasize the potential of research
within clinical practice to (1) contribute to evidence-
based care including better understanding of which inter-
ventions improve their patient outcomes, (2) serve as a
sign that the practice employs state-of-the-art medicine,
and (3) engender professional recognition with peers.
Outreach campaigns would also need to address risks
– perceived by patients and clinicians – of engaging in
clinical research. In particular, outreach campaigns
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tion is exploitative of the clinician or patient. To
increase clinician confidence that they and their patients
will be well-treated, organizations trying to recruit clini-
cians to practice-based research could, in consultation
with clinician and patient representatives, adopt and
enforce a set of clinical research principles emphasizing
value for clinicians and patients as integral components
of the research endeavor. These principles would be
most effective if they are clearly and consistently articu-
lated in all outreach campaigns and embodied in all
aspects of the research process, including the manage-
ment and administrative structures supporting the clini-
cal research endeavor. Emphasizing patient and clinician
participation in IRB committees might also be useful.
Examples of research principles to explicitly guide com-
munity clinician-organization interactions include:
￿ Avoidance of community clinicians being unduly
pressured to participate in clinical research.
￿ Restraint by clinicians of enrollment of so many
patients that they compromise their clinical
responsibilities.
￿ Specification in protocols of all data quality
requirements and procedures.
￿ Assurance that mechanisms are in place to support
that clinicians have rapid and effective feedback of
their data quality (such as through an internet-based
registry).
￿ Commitment by participating clinicians that
patient-poaching by specialists will not be tolerated.
￿ Implementation of publicized research principles to
assure clinicians and their patients that they are valued
as an integral component of the research endeavor.
Finally, clinicians often expressed reluctance to engage
in practice-based research if they believed the clinical
research tasks would be onerous and difficult to incor-
porate into patient care. Healthcare organizations that
seek to promote research among their own clinicians
need to address these commonly perceived barriers –
such as time constraints and lack of staffing and training
– within their own systems and effectively communicate
to clinicians how this will be accomplished.
An effective and comprehensive outreach campaign
will likely require more space and time than most media
can provide. An internet-based registry (such as the one
described in Kahn et al. [6]) could feature a portal that
provides detailed description of the features, benefits,
and requirements of clinical research and that clinicians
can access at their convenience. Table 2 lists strategies
for using a registry to support community-based clini-
cian participation in research. One outreach strategy
that is likely to be even more effective than a media
campaign or a web portal is academic detailing. Aca-
demic detailing involves a short (10-minute) visit or dis-
cussion by an opinion leader or specialized clinician
with a physician, either one-on-one or with a small
group of physicians working in the same practice. Aca-
demic detailing has been found to be an effective
method of changing physician behavior (such as improv-
ing adherence to clinical guidelines) [20,21].
Information-gathering
To help clinicians and medical practices realistically
think through the implications to their practices of clini-
cal research and ways to adjust their office practice,
organizations can provide informational and decision-
making assistance. Such assistance may be most effective
if provided by a highly credible (to the clinician) profes-
sional with several years’ experience working with medi-
cal practices and clinical research.
To address concerns that the reimbursement for
time spent in clinical research activities are too low,
Table 2 An internet-based registry that targets all stages of the model
Model stage
Pre-Awareness The organization can advertise the Web-link in journals and other media/venues that community clinicians routinely use.
Awareness A portal on the registry could outline the personal and professional benefits of clinical research and describe how clinical
research can be incorporated into practice with an emphasis on ways that common barriers will be overcome. The registry
could also summarize a set of clinical research principles adopted by the organization to emphasize that clinicians and patients
will be treated with integrity. A portal with a chat room could allow interested clinicians to talk with clinicians currently
involved in clinical research about their experiences confidentially.
Information-
gathering
Each research study can be characterized on the Web in terms of: objectives; expected benefits to science, patients and
clinicians, including reimbursement rates; potential risks; types of tasks; and resources required. A registry can also post current
and upcoming protocols so that clinicians can assess the predictability of clinical research studies over time.
First protocol Web-links to research training, including IRB-training and patient-consenting procedures as well as specifics for a particular
protocol, can be included. The registry can provide confirmation of the receipt of data/specimens and feedback about data
quality and problems to confidentially assist clinicians to improve. Electronic chat sessions within the registry can provide peer
support and a sense of community.
Maintenance The registry can provide confirmation of the receipt of data/specimens and feedback about data quality and problems to
confidentially assist clinicians to improve. Electronic chat sessions within the registry can provide peer support and a sense of
community.
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for clinicians or, if the organizations themselves or a ven-
dor are setting reimbursement rates, they can develop a
reimbursement schedule for specific research tasks. These
schedules can be posted in an easy-to-understand format
on a website or in print. Transparent and easy-to-use
information on reimbursement rates for a research proto-
col can be useful for clinicians who are selecting their first
or subsequent protocol. Organizations can also identify
procedures and visits that are covered by health insurance
on behalf of practices. Organizations can help clinicians
calculate whether staff time is covered, and whether this
coverage is sufficient, as well as develop review checklists
for costs. Clinicians may also need help determining
whether their liability coverage is appropriate for engaging
in research.
To provide clinicians with realistic expectations about
what they would be expected to do prior to committing
to participate in their first clinical research study, the
internet-based registry can list all current and upcoming
protocols along with associated tasks, clinician experi-
ence and training requirements, exclusionary criteria,
and reimbursement schedule. Electronic chat sessions
for clinicians interested in clinical research could contri-
bute to a sense of community and provide a way for
clinicians in the information-gathering stage to obtain
advice from clinicians currently engaged in clinical
research.
Participating in a research study
Although this did not emerge from our discussions with
clinicians, healthcare organizations can facilitate the
completion of a clinician’s first study at every step.
Organizations can provide informational and instrumen-
tal assistance, ranging from selection of a protocol that
is a good fit for practice resources and limitations, to
thoroughly understanding and meeting protocol and
training requirements. If a clinician fails to meet a
requirement or does not understand the need for a spe-
cific supporting document, assistance can be given to
overcome such obstacles. Links to training sites and
other information can also be made accessible on the
internet-based registry. In addition, the registry can help
clinicians and organizations track completion of eligibil-
ity requirements. Organizations can also help commu-
nity clinicians set enrollmentg o a l sa n di n t e r v e n ei ft h e
clinician falls short of these goals. For example, a work-
sheet might guide efforts to ensure that processes and
staff are in place to meet study timelines and data qual-
ity assurance processes; help identify certified labora-
tories and pharmacies; and coordinate referrals for
multi-clinician studies meet all administrative require-
ments. A healthcare organization can also ensure that
clinicians are provided with the technical and
technological support, along with user support, needed
to incorporate clinical research more easily into their
practices.
Two other ways organizations can support clinicians
during their initial research experiences are by rigor-
ously applying and enforcing principles of research
throughout the protocol and by promoting a sense of
community. Venues like internet chat rooms that
encourage clinicians to express themselves might help
foster this sense of community, if such resources are
accessed.
Maintenance
The need to foster a sense of community among clini-
cians who participate in research continues after the
first research experience, even if subsequent research
projects require less administrative and technical sup-
port. Organizations, in conjunction with other clinician
researchers, can foster a sense of community and
responsibility for the research enterprise among all prac-
ticing clinicians involved in clinical research. For exam-
ple, clinicians can be recognized at local and national
meetings for their participation in research and encour-
aged to give presentations describing their research
involvement and their particular studies and outcomes.
Organizations can solicit clinician input on study topics
and protocol development and channel this information
to study sponsors. In turn, this could improve protocol
applicability in community settings and communicate to
clinicians that they are valued for their clinical expertise.
A confidential venue (such as through a registry portal)
could be provided for clinicians’‘ voices’ to be heard and
for clinicians to register complaints or concerns about
current and future protocols and ensure that protocols
are feasible in their community settings.
Strategies and organizational limitations
Not all of the strategies outlined above are suitable for
all types of organizations that might be interested in
supporting clinician involvement in clinical research,
and may not apply to all clinical settings. Table 3 sum-
marizes the levels of centralization and organizational
size that might be required to successfully implement
each strategy, consistent with the opinions expressed by
our interviewees. A highly centralized healthcare organi-
zation is one that employs and directly influences the
way its clinicians practice (such as a staff-model health
maintenance organization, or HMO). A less centralized
organization might be a specialty society that represents
its members but exerts no control over them. The size
of an organization can indicate its capacity to run multi-
ple studies over time, reflecting the number of clinicians
and patients involved in the organization and how much
of the business can be devoted to research. Some
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demic health centers (AHCs) and large multispecialty
clinics with a substantial research focus such as Kaiser-
Permanente, Palo Alto Medical Clinic, Fallon Clinic,
Marshfield Clinic, and the Mayo Clinic.
Some of these approaches require a large, highly cen-
tralized organization (or highly centralized coalitions of
smaller organizations), whereas others will require sig-
nificant additional resources. Developing a registry and
designing relevant research questions are likely to be the
most challenging steps to fostering research: the cost
and effort required to develop a registry and promote
relevant research questions are best born by higher
levels of organizational management that have control
over sufficient resources to make them happen. Conver-
sely, development and dissemination of research princi-
ples and the setting of reimbursement rates need to be
completed at a relatively high level within an organiza-
tion and require a high degree of centralization,
although neither of these latter two approaches is parti-
cularly dependent upon the size of the organization.
Regardless of the size of the organization, senior lea-
dership is critical to changing an organization’sc u l t u r e
from one where research is not widely accepted to one
where staff and management support and actively
engage in clinical research. Senior leadership has been
essential in changing physician behaviors, such as the
adoption and use of new chronic disease management
strategies within organizations [22]. Senior leadership is
able to affect physician change by assessing challenges
and opportunities within the organization, setting per-
formance expectations for all staff and clinicians, align-
ing structures and functions, and engaging others within
the organization [23]. In other words, senior manage-
ment needs to be involved in all stages of the effort to
change an organization’s culture and its physician
performance so that clinical research is valued and
practiced.
Summary
In this article, we outline a model for thinking about
how organizations can influence community clinicians’
decision-making about becoming or remaining involved
in clinical research. We recommend a variety of
approaches organizations can take to encourage clini-
cians to become involved in clinical research. The sug-
gested approaches could be used singly or in
combination by organizations to augment individual
clinician efforts and address the realities of clinical prac-
tice today. Some of the solutions we propose, such as
internet portals and chat rooms, have been tried and
have not generally been effective. We believe that more
intensive types of clinician outreach, in particular, aca-
demic detailing, will be necessary to modify physician
behavior with respect to involvement in clinical
research. Web portals and chat rooms, in contrast, are
likely to be most effective in transmitting additional
information to clinicians who are interested or involved
in clinical research and are seeking more specific infor-
mation (e.g., maintenance phase).
Healthcare organizations are a promising vehicle
through which support services can be delivered to
large numbers of clinicians [24]. Accordingly, healthcare
organizations currently leading quality improvement
efforts that target clinical care inefficiencies are excel-
lent candidates for modifying systems to support clinical
research. Some healthcare organizations, such as AHCs
[25], other academic research organizations [26], PBRNs
[17,27], clinical research organizations [28], and clinical
trials networks [29], have a strong tradition of promot-
ing clinical research among affiliated clinicians. Policy-
makers are now recommending the formation of
Table 3 Appropriateness of approach to support community clinician involvement in clinical research by
organizational characteristic, size, and locus of control
Organizational management level
(high versus low)
Size of organization (small
versus large)
Locus of control
Outreach campaign Low or high Small or large Centralized or
decentralized
Provide (or collect and channel to study sponsors)
appropriate research questions
High Large Centralized
Articulate ethical research principles High Small or large Centralized
Registry High Large Centralized
Provide informational and administrative support Low or high Small or large Centralized or
decentralized
Develop transparent reimbursement rates High Small or large Centralized
Provide technological and technical assistance Low or high Small or large Centralized or
decentralized
Promote a sense of community Low or high Small or large Centralized or
decentralized
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zations (like AHCs) and other healthcare organizations
(such as multispecialty groups, HMOs, community hos-
pitals, and ambulatory medical practices) with the goal
of improving desired outcomes (e.g., provision of evi-
dence-based care, improved quality of care scores) [2,3].
NIH’s current focus on community clinicians [2] may
heighten the motivation for organizations to support
this group’s efforts to participate in research.
A limitation to our conceptual model of clinician deci-
sion-making for the adoption of clinical research is that
it is based on what clinicians report would influence
their decision to participate or not. We did not observe
their behavior. Self-report by clinicians does not always
track behavior. Thus, the proposed approaches to
improving clinician involvement in the research endea-
vor should be subjected to empirical study.
Our review of the literature on clinical trial design
reveals numerous recommendations aimed at enhan-
cing participation in practice-based research that are
consistent with the model we have developed. These
recommendations include outreach to clinicians (and
patients) about the importance of clinical research, dis-
tribution of research tasks among clinic staff, standar-
dization of data collection procedures, and
dissemination of technology to alert clinicians automa-
tically about upcoming clinical trials [10,14,19,30,31].
Such approaches have thus far had a modest impact
[17]. More effort is needed to increase incentives and
remove barriers to improve community clinician
recruitment and long-term involvement in clinical
research [8,32].
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